Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro

Non-alcoholic fatty liver (NAFLD) is a widespread disease with various complications including Non-alcoholic steatohepatitis (NASH) that could lead to cirrhosis and ultimately hepatocellular carcinoma (HCC). Up till now there is no FDA approved drug for treatment of NAFLD. Flavonoids such as Rhamnet...

Descripción completa

Detalles Bibliográficos
Autores principales: Shatta, Mahmoud A., El-Derany, Marwa O., Gibriel, Abdullah A., El-Mesallamy, Hala O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267014/
https://www.ncbi.nlm.nih.gov/pubmed/36495373
http://dx.doi.org/10.1007/s11010-022-04619-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267014/
https://www.ncbi.nlm.nih.gov/pubmed/36495373
http://dx.doi.org/10.1007/s11010-022-04619-6

Ejemplares similares